Medinol has received approval from the US Food and Drug Administration (FDA) to sell its PioNIR Plus stent. This is on the basis of the results of a comprehensive trial of the product that was completed a year ago. The PioNIR Plus stent, also sold under the name Presillion Plus, is a stent developed by Medinol for coronary arteries. It is of the ‘bare metal’ type, meaning the stents are not coated with medication.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments